Table 3. Cancer staging comparison Apr 2020 to Sep 2020 versus Oct 2019 to Mar 2020. Number of cases and percentage early versus late stage.
| Oct 2019 to Mar 2020 | April 2020 to Sept 2020 | |||
|---|---|---|---|---|
| Tumour group | Early stage | Late stage | Early stage | Late stage |
| Breast | 162 | 71 | 121 | 54 |
| Colorectal | 53 | 116 | 20 | 57 |
| Lung | 98 | 140 | 61 | 114 |
| Prostate | 259 | 139 | 84 | 48 |
| Overall | 572 | 466 | 286 | 273 |
| Oct 2019 to Mar 2020 | April 2020 to Sept 2020 | Variance (Late stage) |
|||
|---|---|---|---|---|---|
| Tumour group | Early stage | Late stage | Early stage | Late stage | |
| Breast | 69.5% | 30.5% | 69.1% | 30.9% | +0.4% |
| Colorectal | 31.4% | 68.6% | 26.0% | 74.0% | +5.4% |
| Lung | 41.2% | 58.8% | 34.9% | 65.1% | +6.3% |
| Prostate | 65.1% | 34.9% | 63.6% | 36.4% | +1.4% |
| Overall | 55.1% | 44.9% | 51.2% | 48.8% | +3.9% |